70 related articles for article (PubMed ID: 12537668)
1. BCL2 antisense reduces prostate cancer cell survival following irradiation.
Scott SL; Higdon R; Beckett L; Shi XB; deVere White RW; Earle JD; Gumerlock PH
Cancer Biother Radiopharm; 2002 Dec; 17(6):647-56. PubMed ID: 12537668
[TBL] [Abstract][Full Text] [Related]
2. BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents.
Shi XB; Gumerlock PH; Muenzer JT; deVere White RW
Cancer Biother Radiopharm; 2001 Oct; 16(5):421-9. PubMed ID: 11776759
[TBL] [Abstract][Full Text] [Related]
3. Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation.
Rubenstein M; Hollowell CM; Guinan P
In Vivo; 2015; 29(6):687-93. PubMed ID: 26546525
[TBL] [Abstract][Full Text] [Related]
4. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
Gleave M; Tolcher A; Miyake H; Nelson C; Brown B; Beraldi E; Goldie J
Clin Cancer Res; 1999 Oct; 5(10):2891-8. PubMed ID: 10537358
[TBL] [Abstract][Full Text] [Related]
5. Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.
Zellweger T; Chi K; Miyake H; Adomat H; Kiyama S; Skov K; Gleave ME
Clin Cancer Res; 2002 Oct; 8(10):3276-84. PubMed ID: 12374699
[TBL] [Abstract][Full Text] [Related]
6. Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3.
Holzapfel K; Müller SA; Seidl C; Grosu AL; Schwaiger M; Senekowitsch-Schmidtke R
Strahlenther Onkol; 2008 Jun; 184(6):319-24. PubMed ID: 18535808
[TBL] [Abstract][Full Text] [Related]
7. Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors.
Rubenstein M; Tsui P; Guinan P
Med Oncol; 2007; 24(2):189-96. PubMed ID: 17848743
[TBL] [Abstract][Full Text] [Related]
8. Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells.
Berchem GJ; Bosseler M; Sugars LY; Voeller HJ; Zeitlin S; Gelmann EP
Cancer Res; 1995 Feb; 55(4):735-8. PubMed ID: 7850782
[TBL] [Abstract][Full Text] [Related]
9. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.
Lebedeva I; Rando R; Ojwang J; Cossum P; Stein CA
Cancer Res; 2000 Nov; 60(21):6052-60. PubMed ID: 11085527
[TBL] [Abstract][Full Text] [Related]
10. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
11. Enhancing radiosensitivity of Hela cells by combining transfection of bcl-2 c-myc ASODNs.
Li R; Cheng Y; Gao C
Bull Cancer; 2006 Nov; 93(11):E119-25. PubMed ID: 17145575
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.
Anai S; Tanaka M; Shiverick KT; Kim W; Takada S; Boehlein S; Goodison S; Mizokami A; Rosser CJ
J Urol; 2007 May; 177(5):1913-7. PubMed ID: 17437847
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 inhibitors potentiate the cytotoxic effects of radiation in Bcl-2 overexpressing radioresistant tumor cells.
Hara T; Omura-Minamisawa M; Chao C; Nakagami Y; Ito M; Inoue T
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):517-28. PubMed ID: 15667975
[TBL] [Abstract][Full Text] [Related]
15. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC
Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Bcl-2 enhances the efficacy of epirubicin chemotherapy in PC-3 prostate cancer cells.
Jiang H; Xia D; Wu LJ; Chen ZD
Chin Med J (Engl); 2011 Dec; 124(23):4018-21. PubMed ID: 22340335
[TBL] [Abstract][Full Text] [Related]
17. Combined use of antisense oligonucleotides and chemotherapeutics in the treatment of refractory prostate cancer.
Baltogiannis D; Charalabopoulos K; Giannakopoulos X; Karakosta A; Sofikitis N
Exp Oncol; 2005 Jun; 27(2):91-3. PubMed ID: 15995623
[TBL] [Abstract][Full Text] [Related]
18. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer.
Rothermund CA; Kondrikov D; Lin MF; Vishwanatha JK
Prostate Cancer Prostatic Dis; 2002; 5(3):236-45. PubMed ID: 12496988
[TBL] [Abstract][Full Text] [Related]
20. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
Bromfield GP; Meng A; Warde P; Bristow RG
Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
